Chemomab Therapeutics (2QV) Technical Analysis
Technical Sentiment
Overall ConsensusBuy
5Bearish
2Neutral
8Bullish
Technical Analysis ConsensusStrong Buy
0Bearish
1Neutral
2Bullish
Moving Average ConsensusNeutral
5Bearish
1Neutral
6Bullish
1 Day timeframe · Data as of Nov 02, 2026
- Chemomab Therapeutics’s (2QV) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Chemomab Therapeutics is a Neutral.
- Chemomab Therapeutics’s (2QV) 20-Day exponential moving average is EUR 2.94, while Chemomab Therapeutics’s (2QV) share price is EUR 2.94, making it a Buy.
- Chemomab Therapeutics’s (2QV) 50-Day exponential moving average is EUR 2.94, while Chemomab Therapeutics’s (2QV) share price is EUR 2.94, making it a Buy.
Chemomab Therapeutics (2QV) Pivot Points
1 Day timeframe · Data as of Nov 02, 2026
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 2.67 | 2.81 | 2.87 | 3.01 | 3.07 | 3.21 | 3.27 |
| Fibonacci | 2.81 | 2.88 | 2.93 | 3.01 | 3.08 | 3.13 | 3.21 |
Chemomab Therapeutics (2QV) Moving Averages
1 Day timeframe · Data as of Nov 02, 2026
| Period | Simple | Exponential |
|---|---|---|
| MA5 | 2.94Sell | 2.94Neutral |
| MA10 | 2.94Sell | 2.94Sell |
| MA20 | 2.94Buy | 2.94Buy |
| MA50 | 2.94Buy | 2.94Buy |
| MA100 | 2.94Buy | 2.94Buy |
| MA200 | 2.94Sell | 2.94Sell |
- Chemomab Therapeutics’s (2QV) 10-Day exponential moving average is EUR 2.94, while Chemomab Therapeutics’s (2QV) share price is EUR 2.94, making it a Sell.
- Chemomab Therapeutics’s (2QV) 100-Day exponential moving average is EUR 2.94, while Chemomab Therapeutics’s (2QV) share price is EUR 2.94, making it a Buy.
- Chemomab Therapeutics’s (2QV) stock price is EUR 2.94 and Chemomab Therapeutics’s (2QV) 50-day simple moving average is EUR 2.94, creating a Buy signal.
- Chemomab Therapeutics’s (2QV) stock price is EUR 2.94 and Chemomab Therapeutics’s (2QV) 100-day simple moving average is EUR 2.94, creating a Buy signal.
- Chemomab Therapeutics’s (2QV) stock price is EUR 2.94 and Chemomab Therapeutics’s (2QV) 200-day simple moving average is EUR 2.94, creating a Sell signal.
Chemomab Therapeutics (2QV) Technical Indicators
1 Day timeframe · Data as of Nov 02, 2026
| Name | Value | Implied Action |
|---|---|---|
| MACD (12,26) | <0.01 | Neutral |
| Williams %R | -100.00 | Buy |
| ATR (14) | 0.20 | - |
| Bull/Bear Power (13) | 0.20 | Buy |
unique trading strategy with a flexible screenerTry it Now!
FAQ
Is 2QV a Buy, Hold, or Sell?
Based on 2QV’s technical indicators on the 1-day timeframe as of Nov 02, 2026, 2QV is a Buy.
What is 2QV’s RSI (14)?
Currently, no data Available
What is 2QV’s MACD?
2QV’s MACD is <0.01, which suggests 2QV is a Neutral.
What is 2QV’s 5-day moving average?
2QV’s 5-day moving average is 2.94, which suggests 2QV is a Sell.
What is 2QV’s 20-day moving average?
2QV 20-day moving average is 2.94, which suggests 2QV is a Buy.
What is 2QV’s 50-day moving average?
2QV’s 50-day moving average is 2.94, which suggests 2QV is a Buy.
What is 2QV’s 200-day moving average?
2QV’s 200-day moving average is 2.94, which suggests 2QV is a Sell.
What is 2QV’s Williams % R (14)?
2QV’s Williams % R (14) is -100.00, which suggests 2QV is a Buy.
What is 2QV’s CCI (14)?
Currently, no data Available
What is the share price of Chemomab Therapeutics?
Chemomab Therapeutics's share price is N/A€.
